CVE-2019-3010

Known Exploited Public Exploit

Description

Vulnerability in the Oracle Solaris product of Oracle Systems (component: XScreenSaver). The supported version that is affected is 11. Easily exploitable vulnerability allows low privileged attacker with logon to the infrastructure where Oracle Solaris executes to compromise Oracle Solaris. While the vulnerability is in Oracle Solaris, attacks may significantly impact additional products. Successful attacks of this vulnerability can result in takeover of Oracle Solaris. CVSS 3.0 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.0/AV:L/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H).

8.8
CVSS
Severity: High
CVSS 3.1 •
CVSS 2.0 •
EPSS 37.16% Top 5%
KEV Since 
Vendor Advisory oracle.com
Affected: Oracle Corporation Solaris Operating System
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2019-3010?
CVE-2019-3010 has been scored as a high severity vulnerability.
How to fix CVE-2019-3010?
To fix CVE-2019-3010, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2019-3010 being actively exploited in the wild?
It is confirmed that CVE-2019-3010 is actively exploited. Be extra cautious if you are using vulnerable components. According to its EPSS score, there is a ~37% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2019-3010?
CVE-2019-3010 affects Oracle Corporation Solaris Operating System.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.